Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI
Academic Radiology · 2026-08
DOI: 10.1016/j.acra.2026.08.033 ↗Kurz gefasst
Fachartikel in der Zeitschrift Academic Radiology, 2026-08. Verfasst von Junjie Zhang und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiology, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer H…. Die Arbeit nennt 33 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Peking University, Guangdong Provincial Medical Research Foundation.
Abstract (Originalsprache)
RATIONALE AND OBJECTIVES: To develop and validate a habitat radiomics model based on pretreatment breast magnetic resonance imaging (MRI) in predicting residual axillary lymph node metastasis (RALNM) after neoadjuvant therapy (NAT) in patients with clinically node-positive (cN+) breast cancer. MATERIALS AND METHODS: This retrospective study included patients with cN+ breast cancer who underwent NAT at two centers between March 2018 and December 2022. Tumor region on pretreatment dynamic contrast-enhanced (DCE) MRI was segmented into distinct habitats using K-means clustering, and radiomics features were extracted from each habitat to build a habitat radiomics model. The conventional radiomics model was developed for comparison. Furthermore, a combined model integrating clinicopathological features with habitat radiomics signature was built. Model performance was evaluated using the area under the receiver operating characteristic curve (AUC). RESULTS: Among 686 included women (mean age ± standard deviation, 49.38 ± 10.37 years), RALNM was present in 351 patients (51.17%) after NAT. The habitat radiomics model achieved AUCs of 0.805 (95% confidence interval [CI]: 0.739-0.872) in the internal validation set and 0.802 (95% CI: 0.734-0.869) in the external test set, significantly outperforming the whole-tumor radiomics model in all cohorts (all p < 0.05). Integration of habitat radiomics with independent clinicopathological predictors yielded a combined model with further improved AUCs of 0.871 (95% CI: 0.816-0.926) and 0.857 (95% CI: 0.800-0.915) in the validation and external test sets, respectively. CONCLUSION: Habitat radiomics analysis of pretreatment breast DCE-MRI demonstrates promising performance for predicting RALNM after NAT. The combined model incorporating habitat radiomics and clinicopathological factors further improves predictive accuracy.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Radiology, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China.
- Department of Medical Imaging, Peking University Shenzhen Hospital, Shenzhen, China.
- Department of Radiology, Shanxi Province Cancer Hospital/ Shanxi Hospital Affiliated to Cancer Hospital, Chinese Academy of Medical Sciences/Cancer Hospital Affiliated to Shanxi Medical University, Taiyuan, China. Elect…
Förderung
- National Natural Science Foundation of China
- Peking University
- Guangdong Provincial Medical Research Foundation
Zitieren
APA
Zhang, J., Dai, Y., Xu, R., Aishanjiang, D., Yin, Z., Cui, Y., & Yang, X. (2026). Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI. Academic Radiology. https://doi.org/10.1016/j.acra.2026.08.033
Vancouver
Zhang J, Dai Y, Xu R, Aishanjiang D, Yin Z, Cui Y, et al. Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI. Academic Radiology. 2026. doi:10.1016/j.acra.2026.08.033
BibTeX
@article{Zhang2026,
author = {Zhang, Junjie and Dai, Yi and Xu, Ruxin and Aishanjiang, Dilinuer and Yin, Zhi and Cui, Yanfen and Yang, Xiaotang},
title = {Prediction of Residual Axillary Lymph Node Metastasis Following Neoadjuvant Therapy for Breast Cancer: Habitat Radiomics Analysis Based on Breast MRI},
journal = {Academic Radiology},
year = {2026},
doi = {10.1016/j.acra.2026.08.033}
}
EUVIMED